Drug Farm, a private biotechnology company pioneering the use of genetics and artificial intelligence to discover and develop innovative immune-modulating therapies, announced today that it has entered into a Material Transfer Agreement (MTA) with Cincinnati Children’s Hospital Medical Center (CCHMC).…
Merck, a leading science and technology company, and Siemens, a global technology leader, have announced the signing of a new Memorandum of Understanding (MoU) that significantly extends their ongoing strategic partnership. The agreement is designed to accelerate digital transformation in…
Exact Sciences Corp., a leader in cancer screening and diagnostic testing, has announced a new awareness campaign in collaboration with actor and horror film icon Matthew Lillard. The initiative aims to motivate adults aged 45 and older to get screened…
Bayer announced significant progress today in its efforts to develop new treatment options for Parkinson’s disease (PD), a chronic and progressive neurodegenerative disorder that affects millions of people worldwide. The company reported two important clinical trial milestones: the initiation of…
Genentech’s Giredestrant Boosts PFS in ER+ Advanced Breast Cancer Genentech, a member of the Roche Group, announced encouraging results from the Phase III evERA study evaluating its investigational oral selective estrogen receptor degrader (SERD), giredestrant, in combination with everolimus. The…
Aptar Pharma, a global leader in drug delivery and active material science solutions, announced that its Unidose Liquid System (UDS) has been selected as the delivery technology for Enbumyst™ (Bumetanide Nasal Spray) 0.5 mg, recently approved by the U.S. Food…
VectorY Therapeutics, a biotechnology company pioneering vectorized antibody therapies for neurodegenerative diseases, and Shape Therapeutics Inc. (“ShapeTX”), a leader in applying AI and RNA technologies to engineer next-generation genetic medicines, announced today that they have entered into an option and…
Immuto Scientific today announced the closing of an oversubscribed $8 million Seed 2 financing round alongside a new drug discovery collaboration with Daiichi Sankyo, a leading global pharmaceutical company. The funding and collaboration represent significant milestones for Immuto as it…
NucleoBio, Corp., a biotechnology innovator in precision oncology diagnostics, has announced a new strategic collaboration with PreCheck Health Services, a high-complexity CLIA-certified and CAP-accredited clinical laboratory. The partnership will support the clinical development and processing of Prostac™, NucleoBio’s proprietary diagnostic…
C-Further today announced that Great Ormond Street Hospital Charity (GOSH Charity), the UK’s largest dedicated charitable funder of child health research, has joined Cancer Research Horizons and LifeArc as a core partner in the international consortium. Together, the organizations will…
Geneos Therapeutics, a clinical-stage biotherapeutics company pioneering personalized immunotherapies for cancer (PICs), has announced remarkable clinical results from two long-term patients treated with its novel DNA-based therapy. One patient with glioblastoma multiforme (GBM), an aggressive brain cancer, and another with…
Almirall, S.A., a global biopharmaceutical company dedicated to medical dermatology, announced new long-term results from the POSITIVE study, presented as a late-breaker at the 34th Congress of the European Academy of Dermatology and Venereology (EADV 2025) in Paris. The POSITIVE…